|
1
|
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.
|
J Neurovirol
|
2010
|
7.56
|
|
2
|
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases.
|
Lancet Neurol
|
2010
|
5.03
|
|
3
|
Age and cigarette smoking are independently associated with the cutaneous vascular response to local warming.
|
Microcirculation
|
2009
|
2.05
|
|
4
|
Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome.
|
J Virol
|
2011
|
1.85
|
|
5
|
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations.
|
Pain
|
2010
|
1.84
|
|
6
|
Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera.
|
J Infect Dis
|
2007
|
1.79
|
|
7
|
Robust crop resistance to broadleaf and grass herbicides provided by aryloxyalkanoate dioxygenase transgenes.
|
Proc Natl Acad Sci U S A
|
2010
|
1.69
|
|
8
|
Clinical factors related to brain structure in HIV: the CHARTER study.
|
J Neurovirol
|
2011
|
1.57
|
|
9
|
Peripheral neuropathy in HIV: prevalence and risk factors.
|
AIDS
|
2011
|
1.53
|
|
10
|
Low atazanavir concentrations in cerebrospinal fluid.
|
AIDS
|
2009
|
1.45
|
|
11
|
Hypnosis for treatment of HIV neuropathic pain: a preliminary report.
|
Pain Med
|
2013
|
1.44
|
|
12
|
Regional patterns of brain metabolites in AIDS dementia complex.
|
Neuroimage
|
2004
|
1.40
|
|
13
|
AIDS and AIDS-treatment neuropathies.
|
Curr Pain Headache Rep
|
2002
|
1.39
|
|
14
|
Differential input by Ste5 scaffold and Msg5 phosphatase route a MAPK cascade to multiple outcomes.
|
EMBO J
|
2004
|
1.27
|
|
15
|
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
|
Toxicon
|
2013
|
1.27
|
|
16
|
JC virus granule cell neuronopathy is associated with VP1 C terminus mutants.
|
J Gen Virol
|
2011
|
1.25
|
|
17
|
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV.
|
J Antimicrob Chemother
|
2010
|
1.19
|
|
18
|
Neurocognitive impact of substance use in HIV infection.
|
J Acquir Immune Defic Syndr
|
2011
|
1.16
|
|
19
|
Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy.
|
J Neurovirol
|
2013
|
1.10
|
|
20
|
Sex-specific programming of cardiovascular physiology in children.
|
Eur Heart J
|
2008
|
1.10
|
|
21
|
Diagnosis and management of HIV-associated neuropathy.
|
Neurol Clin
|
2008
|
1.09
|
|
22
|
Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy.
|
Ann Neurol
|
2008
|
1.08
|
|
23
|
Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.
|
Clin Infect Dis
|
2013
|
1.05
|
|
24
|
Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN.
|
Epilepsia
|
2012
|
1.04
|
|
25
|
Size at birth and autonomic function during psychological stress.
|
Hypertension
|
2007
|
1.01
|
|
26
|
Neuromuscular diseases associated with HIV-1 infection.
|
Muscle Nerve
|
2009
|
0.99
|
|
27
|
Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome.
|
Toxicon
|
2012
|
0.98
|
|
28
|
A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy.
|
J Acquir Immune Defic Syndr
|
2012
|
0.97
|
|
29
|
A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain.
|
PLoS One
|
2007
|
0.97
|
|
30
|
Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study.
|
Arch Phys Med Rehabil
|
2009
|
0.96
|
|
31
|
The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study.
|
J Acquir Immune Defic Syndr
|
2009
|
0.95
|
|
32
|
Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir.
|
J Acquir Immune Defic Syndr
|
2012
|
0.95
|
|
33
|
Role of metabolic syndrome components in HIV-associated sensory neuropathy.
|
AIDS
|
2009
|
0.95
|
|
34
|
Objective detection of evoked potentials using a bootstrap technique.
|
Med Eng Phys
|
2006
|
0.94
|
|
35
|
HIV-related neurocognitive impairment in the HAART era.
|
Curr HIV/AIDS Rep
|
2009
|
0.93
|
|
36
|
Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.
|
Arch Neurol
|
2008
|
0.93
|
|
37
|
Localized feedback phosphorylation of Ste5p scaffold by associated MAPK cascade.
|
J Biol Chem
|
2004
|
0.92
|
|
38
|
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection.
|
J Neurovirol
|
2013
|
0.91
|
|
39
|
Detection of impaired cerebral autoregulation improves by increasing arterial blood pressure variability.
|
J Cereb Blood Flow Metab
|
2012
|
0.91
|
|
40
|
Managing HIV peripheral neuropathy.
|
Curr HIV/AIDS Rep
|
2007
|
0.91
|
|
41
|
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.
|
J Antimicrob Chemother
|
2012
|
0.90
|
|
42
|
Peripheral neuropathies associated with HIV and hepatitis C co-infection: a review.
|
AIDS
|
2005
|
0.90
|
|
43
|
Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain.
|
J Pain Res
|
2011
|
0.89
|
|
44
|
Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity.
|
Psychosomatics
|
2012
|
0.89
|
|
45
|
Neuromuscular complications of human immunodeficiency virus infection.
|
Phys Med Rehabil Clin N Am
|
2008
|
0.88
|
|
46
|
NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials.
|
AIDS Res Ther
|
2013
|
0.86
|
|
47
|
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy.
|
J Neurovirol
|
2006
|
0.86
|
|
48
|
Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat.
|
J Neurovirol
|
2012
|
0.85
|
|
49
|
Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.
|
J Neurovirol
|
2012
|
0.85
|
|
50
|
Botulinum toxin for neuropathic pain and spasticity: an overview.
|
Pain Manag
|
2014
|
0.85
|
|
51
|
Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study.
|
AIDS Res Ther
|
2011
|
0.85
|
|
52
|
Anatomical localization of motor endplate bands in the human biceps brachii.
|
J Clin Neuromuscul Dis
|
2007
|
0.85
|
|
53
|
Heart-rate and blood-pressure variability during psychophysiological tasks involving speech: influence of respiration.
|
Psychophysiology
|
2007
|
0.84
|
|
54
|
Simplification of the research diagnosis of HIV-associated sensory neuropathy.
|
HIV Clin Trials
|
2009
|
0.84
|
|
55
|
Therapeutic amprenavir concentrations in cerebrospinal fluid.
|
Antimicrob Agents Chemother
|
2012
|
0.84
|
|
56
|
Postural sway changes during pregnancy: a descriptive study using stabilometry.
|
Eur J Obstet Gynecol Reprod Biol
|
2009
|
0.84
|
|
57
|
Peripheral neuropathy in HIV infection.
|
Handb Clin Neurol
|
2007
|
0.84
|
|
58
|
Contralateral weakness following botulinum toxin for poststroke spasticity.
|
Muscle Nerve
|
2012
|
0.83
|
|
59
|
Reliability and sensitivity of a wrist rig to measure motor control and spasticity in poststroke hemiplegia.
|
Neurorehabil Neural Repair
|
2008
|
0.83
|
|
60
|
Understanding the etiology and management of HIV-associated peripheral neuropathy.
|
Curr HIV/AIDS Rep
|
2014
|
0.81
|
|
61
|
Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons.
|
J Neuropsychiatry Clin Neurosci
|
2011
|
0.81
|
|
62
|
Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment.
|
Virology
|
2012
|
0.81
|
|
63
|
HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter.
|
J Neurovirol
|
2014
|
0.81
|
|
64
|
Cdc24 regulates nuclear shuttling and recruitment of the Ste5 scaffold to a heterotrimeric G protein in Saccharomyces cerevisiae.
|
J Biol Chem
|
2005
|
0.81
|
|
65
|
Pathways in the diagnosis and management of diabetic polyneuropathy.
|
Curr Diab Rep
|
2015
|
0.81
|
|
66
|
Problematic prescription opioid use in an HIV-infected cohort: the importance of universal toxicology testing.
|
J Acquir Immune Defic Syndr
|
2012
|
0.81
|
|
67
|
Neuromuscular complications in HIV: effects of aging.
|
J Neurovirol
|
2011
|
0.80
|
|
68
|
HIV neuropathy.
|
Curr Opin HIV AIDS
|
2014
|
0.80
|
|
69
|
Effects of assisted and variable mechanical ventilation on cardiorespiratory interactions in anesthetized pigs.
|
Physiol Meas
|
2012
|
0.79
|
|
70
|
The relationship between upper limb activity and impairment in post-stroke hemiplegia.
|
Disabil Rehabil
|
2009
|
0.79
|
|
71
|
The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.
|
Am J Epidemiol
|
2014
|
0.79
|
|
72
|
Low-frequency heart rate variability is related to the breath-to-breath variability in the respiratory pattern.
|
Psychophysiology
|
2013
|
0.78
|
|
73
|
A system identification analysis of neural adaptation dynamics and nonlinear responses in the local reflex control of locust hind limbs.
|
J Comput Neurosci
|
2012
|
0.78
|
|
74
|
Random perturbations of arterial blood pressure for the assessment of dynamic cerebral autoregulation.
|
Physiol Meas
|
2012
|
0.78
|
|
75
|
Ste11p MEKK signals through HOG, mating, calcineurin and PKC pathways to regulate the FKS2 gene.
|
BMC Mol Biol
|
2011
|
0.78
|
|
76
|
The dynamics of analogue signalling in local networks controlling limb movement.
|
Eur J Neurosci
|
2012
|
0.77
|
|
77
|
Understanding neuronal systems in movement control using Wiener/Volterra kernels: a dominant feature analysis.
|
J Neurosci Methods
|
2011
|
0.77
|
|
78
|
Gain and coherence estimates between respiration and heart-rate: differences between inspiration and expiration.
|
Auton Neurosci
|
2013
|
0.77
|
|
79
|
Tracking instantaneous pressure-to-flow dynamics of cerebral autoregulation induced by CO2 reactivity.
|
Conf Proc IEEE Eng Med Biol Soc
|
2013
|
0.77
|
|
80
|
Comparison of human expert and computer-automated systems using magnitude-squared coherence (MSC) and bootstrap distribution statistics for the interpretation of pattern electroretinograms (PERGs) in infants with optic nerve hypoplasia (ONH).
|
Doc Ophthalmol
|
2015
|
0.77
|
|
81
|
Pilot study of intravenous immunoglobulin in HIV-associated myelopathy.
|
AIDS Patient Care STDS
|
2009
|
0.76
|
|
82
|
Safety profile of treatment in diabetic peripheral neuropathic pain.
|
Pain Med
|
2007
|
0.76
|
|
83
|
Challenges in developing novel therapies for peripheral neuropathies: a summary of The Foundation for Peripheral Neuropathy Scientific Symposium 2012.
|
J Peripher Nerv Syst
|
2013
|
0.76
|
|
84
|
Spastic cocontraction in hemiparesis: effects of botulinum toxin.
|
Muscle Nerve
|
2012
|
0.76
|
|
85
|
Myopathy in HIV infection.
|
Handb Clin Neurol
|
2007
|
0.76
|
|
86
|
Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia.
|
Curr HIV Res
|
2016
|
0.76
|
|
87
|
Revisiting the frequency domain: the multiple and partial coherence of cerebral blood flow velocity in the assessment of dynamic cerebral autoregulation.
|
Physiol Meas
|
2016
|
0.76
|
|
88
|
Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy.
|
Pain
|
2015
|
0.75
|
|
89
|
Cutaneous vascular response to local warming: a response to letter from Cracowski and Roustit.
|
Microcirculation
|
2010
|
0.75
|
|
90
|
Optimizing measures of HIV-associated neuropathy.
|
Muscle Nerve
|
2014
|
0.75
|
|
91
|
Assessing cerebral blood flow control from variability in blood pressure and arterial CO2 levels.
|
Conf Proc IEEE Eng Med Biol Soc
|
2015
|
0.75
|
|
92
|
Poster 308 Improvement of Spasticity, Active Movements and Active Function after Repeated Injections of AbobotulinumtoxinA (Dysport) in Adults with Spastic Paresis in the Upper Limb: Results of a Phase III Open-Label Extension Study.
|
PM R
|
2016
|
0.75
|
|
93
|
Poster 354 OnabotulinumtoxinA to Treat Common Postures in Post-Stroke Lower Limb Spasticity: Identification of a Treatment Paradigm.
|
PM R
|
2016
|
0.75
|
|
94
|
Chronic pain disorders in HIV primary care: clinical characteristics and association with healthcare utilization.
|
Pain
|
2016
|
0.75
|
|
95
|
Stress and cortisol in disaster evacuees: an exploratory study on associations with social protective factors.
|
Appl Psychophysiol Biofeedback
|
2015
|
0.75
|
|
96
|
Imaging findings of atypical mycobacterial infection in the temporal bone.
|
Clin Imaging
|
2012
|
0.75
|
|
97
|
Adaptive feedback analysis and control of programmable stimuli for assessment of cerebrovascular function.
|
Med Biol Eng Comput
|
2013
|
0.75
|
|
98
|
Poster 371 Escalating Doses of IncobotulinumtoxinA (400-800U) Are Well Tolerated and Lead to Increasing Improvements in Disability Due to Multifocal Upper- and Lower-Limb Spasticity.
|
PM R
|
2016
|
0.75
|